GlaxoSmithKline Pharma surges on open offer by parent

Shares in GlaxoSmithKline Pharmaceuticals Ltd surged as much as 20 percent after GlaxoSmithKline Plc (GSK) said on Monday it plans to buy up to 20.6 million shares to raise its stake in its Indian unit.

GSK is offering to buy the shares at 3,100 rupees per share, a premium of 26 percent over the market price on Friday, in a deal worth up to 629 million pounds that would raise its stake in GlaxoSmithKline Pharmaceuticals to up to 75 percent from 50.7 percent.

Post new comment

E-mail ID will not be published
This question is for testing whether you are a human visitor and to prevent automated spam submissions.


  • Amit Shah deserved to be crowned President of India, some say

    The Bharatiya Janata Party is now firmly in the hands of Modi’s alter ego, which in plain English means ‘another side of oneself, a second self’


Stay informed on our latest news!


GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India


Arun Nigavekar

Necessary yet inadequate boost to education

The finance minister, in the very first minutes of his ...

Zehra Naqvi

We must overcome the fear of death

It is the biggest irony that the only thing that’s ...

Dharmendra Khandal

Jawai leopards and locals can coexist peacefully

At first glance, the Jawai landscape seems like a large ...


William D. Green

Chairman & CEO, Accenture